Diseases, Conditions, Syndromes

Tudorza pressair approved for COPD

(HealthDay) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) ...

Immunology

Homes with high ventilation rates tied to respiratory issues

(HealthDay)—People living in homes with high average air exchange rates (AAERs) are more likely to report chronic cough, asthma, or asthma-like symptoms, according to a study published in the February issue of Environmental ...

Diseases, Conditions, Syndromes

Anoro ellipta approved for COPD

(HealthDay)—A new inhaled drug to treat a serious lung condition called chronic obstructive pulmonary disease (COPD) has been approved by the U.S. Food and Drug Administration.

Diseases, Conditions, Syndromes

COPD diagnosis study finds spirometry underused, misdiagnosis common

According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in ...

Cardiology

Innovative imaging and surgery treats lymph condition in adults

Researchers who developed a safe and effective procedure to remove thick clogs in children's airways are now reporting similar success in adult patients. In this rare condition, called plastic bronchitis, patients develop ...

Diseases, Conditions, Syndromes

Bioactive paper will revolutionize point-of-care diagnostics

A pair of University researchers have received a $600,000 CIHR award to develop a bioactive paper that aims to provide an inexpensive, point-of-care diagnostic tool to measure bronchitis in patients with airway diseases, ...

page 2 from 5